|
FR14523E
(fr)
|
1911-02-06 |
1911-12-30 |
Daniel German Caswell |
Perfectionnements dans les vélocipèdes
|
|
US4326055A
(en)
|
1977-12-22 |
1982-04-20 |
Hoffmann-La Roche Inc. |
Stilbene derivatives
|
|
DE3202100A1
(de)
|
1982-01-23 |
1983-08-04 |
Basf Ag, 6700 Ludwigshafen |
Substituierte benzoesaeure-4-hydroxyanilide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
|
|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
DE69224660C5
(de)
|
1991-12-18 |
2010-06-02 |
The Salk Institute For Biological Studies, La Jolla |
Mitteln zur modulierung von verfahren durch retinoid rezeptoren und dafür nützliche verbindungen
|
|
DE10199033I2
(de)
|
1992-04-22 |
2003-01-09 |
Ligand Parmaceuticals Inc |
Retinoid-x Rezeptor selektive Verbindungen
|
|
US5780676A
(en)
|
1992-04-22 |
1998-07-14 |
Ligand Pharmaceuticals Incorporated |
Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
|
|
US5466861A
(en)
|
1992-11-25 |
1995-11-14 |
Sri International |
Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors
|
|
JPH08511027A
(ja)
|
1993-01-11 |
1996-11-19 |
リガンド・ファーマシューティカルズ・インコーポレーテッド |
レチノイドｘレセプターに対して選択的な活性を有する化合物、およびレチノイドｘレセプターによって媒体されたプロセスの調節手段
|
|
ATE187434T1
(de)
|
1993-01-11 |
1999-12-15 |
Ligand Pharm Inc |
Selektivitaet fuer retinoid x rezeptoren enthaltende verbindungen
|
|
US5399586A
(en)
|
1993-03-11 |
1995-03-21 |
Allergan, Inc. |
Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity
|
|
EP0694078A4
(en)
|
1993-04-07 |
1997-06-25 |
Ligand Pharm Inc |
SORTING PROCESS RELATING TO RECEPTOR AGONISTS
|
|
ES2133798T3
(es)
|
1994-08-10 |
1999-09-16 |
Hoffmann La Roche |
Ligandos del receptor x del acido retinoico.
|
|
CA2208981C
(en)
|
1994-12-30 |
2008-08-26 |
Ligand Pharmaceuticals Incorporated |
Novel trienoic retinoid compounds and methods
|
|
US5721103A
(en)
|
1994-12-30 |
1998-02-24 |
Ligand Pharmaceuticals Incorporated |
Trienoic retinoid compounds and methods
|
|
JPH09330101A
(ja)
|
1996-06-13 |
1997-12-22 |
Kokusai Chodendo Sangyo Gijutsu Kenkyu Center |
制御装置及び方法
|
|
IT1286031B1
(it)
|
1996-10-24 |
1998-07-07 |
Enichem Spa |
Procedimento per la produzione di polimeri vinilaromatici ad elevato grado di sindiotassia
|
|
US6969711B2
(en)
|
1997-05-26 |
2005-11-29 |
Kowa Company, Ltd. |
Cyclic diamine compounds and medicine containing the same
|
|
US6316503B1
(en)
|
1999-03-15 |
2001-11-13 |
Tularik Inc. |
LXR modulators
|
|
WO2001041704A2
(en)
|
1999-12-13 |
2001-06-14 |
Merck & Co., Inc. |
Method for the prevention and/or treatment of atherosclerosis
|
|
US20030086923A1
(en)
|
1999-12-13 |
2003-05-08 |
Sparrow Carl P. |
Method for the prevention and/or treatment of atherosclerosis
|
|
US7482366B2
(en)
|
2001-12-21 |
2009-01-27 |
X-Ceptor Therapeutics, Inc. |
Modulators of LXR
|
|
WO2003059884A1
(en)
|
2001-12-21 |
2003-07-24 |
X-Ceptor Therapeutics, Inc. |
Modulators of lxr
|
|
US6828446B2
(en)
|
2001-12-21 |
2004-12-07 |
Pharmacia Corporation |
Aromatic thioether liver X-receptor modulators
|
|
AU2003217276A1
(en)
|
2002-02-28 |
2003-09-16 |
Eli Lilly And Company |
Method of treating atherosclerosis and hypercholesterolemia
|
|
MXPA04011691A
(es)
|
2002-05-24 |
2005-09-12 |
Pharmacia Corp |
Moduladores del receptor x anilino hepaticos.
|
|
MXPA04011690A
(es)
|
2002-05-24 |
2005-03-31 |
Pharmacia Corp |
Moduladores de receptor x de higado de sulfona.
|
|
MXPA05002914A
(es)
|
2002-09-17 |
2005-05-27 |
Pharmacia Corp |
Moduladores de los receptores x hepaticos aromaticos.
|
|
WO2004058175A2
(en)
|
2002-12-23 |
2004-07-15 |
Irm Llc |
Novel use of liver x receptor agonists
|
|
US20050009837A1
(en)
|
2003-05-20 |
2005-01-13 |
City Of Hope |
Modulators of lipid metabolism and methods of use
|
|
JP2005128010A
(ja)
*
|
2003-10-03 |
2005-05-19 |
Takeda Chem Ind Ltd |
インスリン抵抗性改善剤のスクリーニング方法
|
|
RU2006124843A
(ru)
|
2003-12-12 |
2008-01-20 |
Уайт (Us) |
Хинолины, пригодные для лечения сердечно-сосудистого заболевания
|
|
JP2008509138A
(ja)
|
2004-08-03 |
2008-03-27 |
ワイス |
心臓血管疾患の治療に有用なインダゾール類
|
|
BRPI0716833A2
(pt)
|
2006-09-19 |
2013-11-05 |
Wyeth Corp |
Uso de agonistas de lxr para o tratamento de osteoartrite
|
|
US9149492B2
(en)
|
2008-10-08 |
2015-10-06 |
Trustees Of Dartmouth College |
Method for selectively inhibiting ACAT1 in the treatment of alzheimer's disease
|
|
JP2012516150A
(ja)
*
|
2009-01-28 |
2012-07-19 |
ザ メディカル リサーチ，インフラストラクチュア，アンド ヘルス サービシーズ ファンド オブ ザ テル アビブ メディカル センター |
炎症性疾患、自己免疫疾患及び循環器疾患におけるエオタキシン−２（ｃｃｌ２４）阻害剤
|
|
JP5719340B2
(ja)
|
2009-03-20 |
2015-05-20 |
レティーナ インプラント アーゲー |
能動型網膜インプラント
|
|
WO2013056232A2
(en)
|
2011-10-13 |
2013-04-18 |
Case Western Reserve University |
Rxr agonists compounds and methods
|
|
MX352727B
(es)
|
2011-12-13 |
2017-12-06 |
Dartmouth College |
Tratamiento de trastorno autoinmune al usar agonistas de rxr.
|
|
WO2015038585A1
(en)
|
2013-09-11 |
2015-03-19 |
Trustees Of Dartmouth College |
Method for selectively inhibiting acat1 in the treatment of alzheimer's disease
|
|
US10286000B2
(en)
|
2013-10-25 |
2019-05-14 |
St. Jude Children's Research Hospital, Inc. |
Retinoid X receptor-gamma agonists and retinoid X receptor-alpha antagonists for treatment of cancer
|
|
US10100308B2
(en)
|
2014-05-29 |
2018-10-16 |
Trustees Of Dartmouth College |
Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
|
|
EP3177322A4
(en)
*
|
2014-08-08 |
2018-07-18 |
Alector LLC |
Anti-trem2 antibodies and methods of use thereof
|
|
CN107708696B
(zh)
|
2015-06-30 |
2021-05-28 |
国立大学法人冈山大学 |
炎症性肠病的预防或治疗用药剂
|
|
WO2017058866A1
(en)
|
2015-09-28 |
2017-04-06 |
Precision Immune, Inc. |
Anti-trem2 antibodies and uses thereof
|
|
AU2016334051B2
(en)
|
2015-10-06 |
2023-10-26 |
Alector Llc |
Anti-TREM2 antibodies and methods of use thereof
|
|
EP3368160B1
(en)
|
2015-10-31 |
2023-05-17 |
IO Therapeutics, Inc. |
Treatment of nervous system disorders using thyroid hormone neutral doses of rxr agonists
|
|
US20190367623A1
(en)
*
|
2017-01-17 |
2019-12-05 |
Yeda Research And Development Co. Ltd. |
Methods of treating neurodegenerative diseases by inducing disease-associated microglia (dam) cells
|
|
JOP20190248A1
(ar)
*
|
2017-04-21 |
2019-10-20 |
Amgen Inc |
بروتينات ربط مولد ضد trem2 واستخداماته
|
|
BR112019022752A2
(pt)
|
2017-08-03 |
2020-05-19 |
Alector Llc |
anticorpos anti-trem2 e métodos de uso dos mesmos
|
|
WO2019118513A1
(en)
|
2017-12-12 |
2019-06-20 |
Pionyr Immunotherapeutics, Inc. |
Anti-trem2 antibodies and related methods
|